AVEO Pharmaceuticals Inc

NASDAQ:AVEO   3:59:54 PM EDT
6.43
-0.15 (-2.28%)
Earnings Announcements

Aveo Oncology Reports Full Year 2020 Financial Results

Published: 03/16/2021 22:11 GMT
AVEO Pharmaceuticals Inc (AVEO) - Aveo Oncology Reports Full Year 2020 Financial Results and Provides Business Update.
Revenue is expected to be $13.81 Million
Adjusted EPS is expected to be -$0.36

Next Quarter Revenue Guidance is expected to be $22.4 Million
Next Quarter EPS Guidance is expected to be -$0.20

More details on our Analysts Page.